首页 > 最新文献

Phytomedicine最新文献

英文 中文
Berberine reverses impaired adipose angiogenesis to promote beige adipogenesis by HIF-1α/PRDM16 signaling 小檗碱通过HIF-1α/PRDM16信号通路逆转受损的脂肪血管生成,促进米色脂肪生成。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-01-31 DOI: 10.1016/j.phymed.2026.157902
Chien-shan Cheng , Jingxian Chen , Yuan Wu , Yijie Song , Jiayue Xu , Yu Xu , Lan Zheng

Background

Obesity-induced adipose tissue expansion is characterized by capillary rarefaction and hypoxia, which disrupts angiogenesis and impairs beige adipogenesis. While angiogenesis is known to be crucial for beiging, the functional link between impaired vascularization and defective browning remains poorly understood. How natural compounds like berberine (BBR) links angiogenesis with beige adipogenesis remains unexplored.

Methods

Using both diet-induced obese (DIO) C57BL/6 J and leptin-deficient (ob/ob) murine models, we administered intraperitoneal BBR for 4 weeks. Adipose tissue remodeling was evaluated through histomorphometry, immunofluorescence, and flow cytometry. RNA sequencing of adipose tissue was performed to identify the potential targets. Chemical hypoxia was induced using CoCl₂ in preadipocytes to examine its effects on browning.

Results

BBR improved adipose tissue dysfunction in both the DIO model and the ob/ob model. It increased CD34+CD31+ endothelial progenitor cells and enhanced protein levels of VEGF/VEGFR2, PRDM16, PPAR-γ, and UCP-1, indicating simultaneous promotion of angiogenesis and adipose browning. Transcriptomic analysis revealed glutathione peroxidase 3 (GPx3) as a novel target through which BBR alleviates adipose dysfunction. GPX3 knockdown in vivo impaired angiogenesis and suppressed browning markers. BBR reversed chemical hypoxia-induced impairment of beige adipocyte differentiation independently of UCP-1 upregulation by inhibiting HIF-1α activation.

Conclusions

This study unveils that BBR counteracts obesity-associated adipose tissue dysfunction: it upregulates GPx3 to reduce oxidative stress, which in turn normalizes HIF-1α levels and activates the PRDM16 signaling, thereby concurrently restoring adipose angiogenesis and promoting beige adipogenesis. This breaks the vicious cycle of hypoxia-impaired angiogenesis and suppressed thermogenesis, positioning BBR as a promising multi-target therapy for obesity.
背景:肥胖引起的脂肪组织扩张以毛细血管稀疏和缺氧为特征,这破坏了血管生成,损害了米色脂肪生成。虽然已知血管生成对北京至关重要,但血管化受损和褐变缺陷之间的功能联系仍然知之甚少。像小檗碱(BBR)这样的天然化合物是如何将血管生成与米色脂肪生成联系起来的,目前还没有研究。方法:采用饮食性肥胖(DIO) C57BL/6 J和瘦素缺乏(ob/ob)小鼠模型,腹腔灌胃BBR 4周。通过组织形态学、免疫荧光和流式细胞术评估脂肪组织重塑。对脂肪组织进行RNA测序以确定潜在靶点。用coc2诱导前脂肪细胞化学缺氧,观察其对褐变的影响。结果:BBR改善了DIO模型和ob/ob模型的脂肪组织功能障碍。它增加了CD34+CD31+内皮祖细胞,提高了VEGF/VEGFR2、PRDM16、PPAR-γ和UCP-1的蛋白水平,表明同时促进了血管生成和脂肪褐变。转录组学分析显示谷胱甘肽过氧化物酶3 (GPx3)是BBR缓解脂肪功能障碍的新靶点。体内GPX3基因敲低会损伤血管生成,抑制褐变标志物。BBR通过抑制HIF-1α激活,逆转化学缺氧诱导的米色脂肪细胞分化损伤,而不依赖于UCP-1的上调。结论:本研究揭示BBR对抗肥胖相关的脂肪组织功能障碍:通过上调GPx3来降低氧化应激,从而使HIF-1α水平正常化,激活PRDM16信号,从而同时恢复脂肪血管生成和促进米色脂肪生成。这打破了缺氧损伤血管生成和抑制产热的恶性循环,使BBR成为一种有前途的多靶点治疗肥胖的方法。
{"title":"Berberine reverses impaired adipose angiogenesis to promote beige adipogenesis by HIF-1α/PRDM16 signaling","authors":"Chien-shan Cheng ,&nbsp;Jingxian Chen ,&nbsp;Yuan Wu ,&nbsp;Yijie Song ,&nbsp;Jiayue Xu ,&nbsp;Yu Xu ,&nbsp;Lan Zheng","doi":"10.1016/j.phymed.2026.157902","DOIUrl":"10.1016/j.phymed.2026.157902","url":null,"abstract":"<div><h3>Background</h3><div>Obesity-induced adipose tissue expansion is characterized by capillary rarefaction and hypoxia, which disrupts angiogenesis and impairs beige adipogenesis. While angiogenesis is known to be crucial for beiging, the functional link between impaired vascularization and defective browning remains poorly understood. How natural compounds like berberine (BBR) links angiogenesis with beige adipogenesis remains unexplored.</div></div><div><h3>Methods</h3><div>Using both diet-induced obese (DIO) C57BL/6 J and leptin-deficient (ob/ob) murine models, we administered intraperitoneal BBR for 4 weeks. Adipose tissue remodeling was evaluated through histomorphometry, immunofluorescence, and flow cytometry. RNA sequencing of adipose tissue was performed to identify the potential targets. Chemical hypoxia was induced using CoCl₂ in preadipocytes to examine its effects on browning.</div></div><div><h3>Results</h3><div>BBR improved adipose tissue dysfunction in both the DIO model and the ob/ob model. It increased CD34<sup>+</sup>CD31<sup>+</sup> endothelial progenitor cells and enhanced protein levels of VEGF/VEGFR2, PRDM16, PPAR-γ, and UCP-1, indicating simultaneous promotion of angiogenesis and adipose browning. Transcriptomic analysis revealed glutathione peroxidase 3 (GPx3) as a novel target through which BBR alleviates adipose dysfunction. GPX3 knockdown <em>in vivo</em> impaired angiogenesis and suppressed browning markers. BBR reversed chemical hypoxia-induced impairment of beige adipocyte differentiation independently of UCP-1 upregulation by inhibiting HIF-1α activation.</div></div><div><h3>Conclusions</h3><div>This study unveils that BBR counteracts obesity-associated adipose tissue dysfunction: it upregulates GPx3 to reduce oxidative stress, which in turn normalizes HIF-1α levels and activates the PRDM16 signaling, thereby concurrently restoring adipose angiogenesis and promoting beige adipogenesis. This breaks the vicious cycle of hypoxia-impaired angiogenesis and suppressed thermogenesis, positioning BBR as a promising multi-target therapy for obesity.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157902"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renqingchangjue ameliorates MNNG-induced chronic atrophic gastritis by inhibiting the TNF/NF-κB/Caspase-3 axis 仁青肠觉通过抑制TNF/NF-κB/Caspase-3轴改善mnng诱导的慢性萎缩性胃炎。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-02-03 DOI: 10.1016/j.phymed.2026.157920
Yuan Chen , Guang Yue , Yanjun Liu , Wei Wang , Ge Jiang , Jinhua Zhang , Zhuo Ga , Yanfei Zhang , Xiaoya Liu , Qingjia Ren , Caolong Li
<div><h3>Background</h3><div>Chronic atrophic gastritis (CAG) is a pivotal premalignant stage in the Correa cascade, characterized by progressive and largely irreversible loss of gastric glands and an elevated risk of gastric cancer. Renqingchangjue (RQCJ), a classical Tibetan multi-herb formula, has demonstrated clinical and pharmacological benefits in gastritis, yet its mechanisms of action in CAG remain inadequately defined.</div></div><div><h3>Purpose</h3><div>This study aims to clarify the therapeutic efficacy and mechanistic basis of RQCJ in CAG.</div></div><div><h3>Methods</h3><div>We established a network pharmacology–bioinformatics workflow to predict potential RQCJ targets in CAG, integrating targets obtained from TCMSP/SwissTargetPrediction with CAG-related genes to construct a STRING protein–protein interaction (PPI) network and perform GO/KEGG enrichment analyses. Constituents were characterized by UHPLC–HRMS/MS. An MNNG-induced CAG mouse model (control group, model group, Weifuchun positive control group, RQCJ low-dose group and RQCJ high-dose group) was validated by histopathology (H&E), immunohistochemistry (IHC), immunofluorescence (IF), TUNEL, ELISA, and Western blot (WB). In vitro, MNNG-injured GES-1 cells were evaluated using CCK-8, scratch wound-healing, and Annexin V–FITC/PI flow cytometry. Mechanistically, RT-qPCR, WB, and reference-based transcriptome sequencing of gastric tissue were employed, and compound druggability was assessed by AutoDock Vina docking.</div></div><div><h3>Results</h3><div>RQCJ markedly ameliorated MNNG-induced chronic atrophic gastritis in vivo and in vitro. UHPLC–HRMS/MS profiling identified 43 constituents, of which 31 were detected as circulating prototypes. Network pharmacology first predicted 154 putative RQCJ–CAG targets enriched in TNF/NF-κB signaling; integrating serum-absorbed component targets with CAG-related genes refined this to 140 high-confidence targets with consistent TNF/NF-κB enrichment. Functionally, RQCJ (20–40 μg/mL) improved GES-1 cell viability and migration while suppressing apoptosis, and in mice dose-dependently repaired gastric mucosal architecture, lowered TNF-α, IL-1β and IL-6, and normalized gastrin and pepsinogen. RQCJ also reduced IL-8, CCL2 and CXCL1 mRNA and increased IL-10 in both models. Mechanistically, it inhibited phosphorylation of IKKβ, IκBα and NF-κB p65 in a dose- and time-dependent manner, decreased cleaved caspase-8/3, restored the Bax/Bcl-2 ratio. Transcriptomics confirmed enrichment of NF-κB and apoptosis pathways, and intersecting differentially expressed genes with the 140 serum-based targets yielded 99 core genes converging on TNF/NF-κB-mediated apoptosis. Molecular docking further supported target engagement, with a chromen-7-ol derivative showing strong predicted affinity for MMP9.</div></div><div><h3>Conclusions</h3><div>Together, these multi-level data indicate that RQCJ exerts clinically relevant protection against CAG via multi-component su
背景:慢性萎缩性胃炎(CAG)是Correa级联中一个关键的癌前阶段,其特征是胃腺的进行性和大部分不可逆的丧失以及胃癌的风险升高。仁青肠觉是一种经典的藏药复方,其治疗胃炎的临床和药理作用已得到证实,但其治疗CAG的作用机制尚不明确。目的:本研究旨在阐明RQCJ治疗CAG的疗效及机制基础。方法:建立网络药理学-生物信息学工作流程预测CAG中潜在的RQCJ靶点,将TCMSP/SwissTargetPrediction获得的靶点与CAG相关基因整合,构建STRING蛋白-蛋白相互作用(STRING protein-protein interaction, PPI)网络,并进行GO/KEGG富集分析。采用UHPLC-HRMS/MS对成分进行表征。采用组织病理学(H&E)、免疫组化(IHC)、免疫荧光(IF)、TUNEL、ELISA、Western blot等方法对mnng诱导的CAG小鼠模型(对照组、模型组、维复春阳性对照组、RQCJ低剂量组和RQCJ高剂量组)进行验证。体外,采用CCK-8、划伤创面愈合和Annexin V-FITC/PI流式细胞术评估mnng损伤的GES-1细胞。在机制上,采用RT-qPCR、WB和基于参考的胃组织转录组测序,并通过AutoDock Vina对接评估复方药物的可药物性。结果:RQCJ在体内外均能显著改善mnng诱导的慢性萎缩性胃炎。UHPLC-HRMS/MS分析鉴定出43种成分,其中31种为循环原型。网络药理学首次预测了154个富含TNF/NF-κB信号的RQCJ-CAG靶点;将血清吸收成分靶点与cag相关基因整合,将其细化为140个高可信度靶点,具有一致的TNF/NF-κB富集。在功能上,RQCJ (20 ~ 40 μg/mL)可提高GES-1细胞活力和迁移能力,抑制细胞凋亡,并在小鼠胃粘膜结构中呈剂量依赖性修复,降低TNF-α、IL-1β和IL-6,并使胃泌素和胃蛋白酶原正常化。RQCJ还降低了两种模型中IL-8、CCL2和CXCL1 mRNA的表达,增加了IL-10的表达。机制上,其抑制IKKβ、i -κ b α和NF-κ b p65磷酸化呈剂量依赖性和时间依赖性,降低裂解caspase-8/3,恢复Bax/Bcl-2比值。转录组学证实了NF-κB和凋亡通路的富集,并将差异表达基因与140个基于血清的靶点相交,获得了99个核心基因,这些基因聚集在TNF/NF-κB介导的凋亡中。分子对接进一步支持了靶标结合,铬-7-醇衍生物显示出对MMP9的强亲和性。结论:这些多层面数据表明,RQCJ通过多组分抑制TNF-NF-κ b /Caspase-3轴、促/抗炎细胞因子的广泛再平衡以及恢复胃功能,对CAG具有临床相关的保护作用。
{"title":"Renqingchangjue ameliorates MNNG-induced chronic atrophic gastritis by inhibiting the TNF/NF-κB/Caspase-3 axis","authors":"Yuan Chen ,&nbsp;Guang Yue ,&nbsp;Yanjun Liu ,&nbsp;Wei Wang ,&nbsp;Ge Jiang ,&nbsp;Jinhua Zhang ,&nbsp;Zhuo Ga ,&nbsp;Yanfei Zhang ,&nbsp;Xiaoya Liu ,&nbsp;Qingjia Ren ,&nbsp;Caolong Li","doi":"10.1016/j.phymed.2026.157920","DOIUrl":"10.1016/j.phymed.2026.157920","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Chronic atrophic gastritis (CAG) is a pivotal premalignant stage in the Correa cascade, characterized by progressive and largely irreversible loss of gastric glands and an elevated risk of gastric cancer. Renqingchangjue (RQCJ), a classical Tibetan multi-herb formula, has demonstrated clinical and pharmacological benefits in gastritis, yet its mechanisms of action in CAG remain inadequately defined.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;This study aims to clarify the therapeutic efficacy and mechanistic basis of RQCJ in CAG.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;We established a network pharmacology–bioinformatics workflow to predict potential RQCJ targets in CAG, integrating targets obtained from TCMSP/SwissTargetPrediction with CAG-related genes to construct a STRING protein–protein interaction (PPI) network and perform GO/KEGG enrichment analyses. Constituents were characterized by UHPLC–HRMS/MS. An MNNG-induced CAG mouse model (control group, model group, Weifuchun positive control group, RQCJ low-dose group and RQCJ high-dose group) was validated by histopathology (H&amp;E), immunohistochemistry (IHC), immunofluorescence (IF), TUNEL, ELISA, and Western blot (WB). In vitro, MNNG-injured GES-1 cells were evaluated using CCK-8, scratch wound-healing, and Annexin V–FITC/PI flow cytometry. Mechanistically, RT-qPCR, WB, and reference-based transcriptome sequencing of gastric tissue were employed, and compound druggability was assessed by AutoDock Vina docking.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;RQCJ markedly ameliorated MNNG-induced chronic atrophic gastritis in vivo and in vitro. UHPLC–HRMS/MS profiling identified 43 constituents, of which 31 were detected as circulating prototypes. Network pharmacology first predicted 154 putative RQCJ–CAG targets enriched in TNF/NF-κB signaling; integrating serum-absorbed component targets with CAG-related genes refined this to 140 high-confidence targets with consistent TNF/NF-κB enrichment. Functionally, RQCJ (20–40 μg/mL) improved GES-1 cell viability and migration while suppressing apoptosis, and in mice dose-dependently repaired gastric mucosal architecture, lowered TNF-α, IL-1β and IL-6, and normalized gastrin and pepsinogen. RQCJ also reduced IL-8, CCL2 and CXCL1 mRNA and increased IL-10 in both models. Mechanistically, it inhibited phosphorylation of IKKβ, IκBα and NF-κB p65 in a dose- and time-dependent manner, decreased cleaved caspase-8/3, restored the Bax/Bcl-2 ratio. Transcriptomics confirmed enrichment of NF-κB and apoptosis pathways, and intersecting differentially expressed genes with the 140 serum-based targets yielded 99 core genes converging on TNF/NF-κB-mediated apoptosis. Molecular docking further supported target engagement, with a chromen-7-ol derivative showing strong predicted affinity for MMP9.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Together, these multi-level data indicate that RQCJ exerts clinically relevant protection against CAG via multi-component su","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157920"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-omics reveals hepatotoxic mechanisms and key toxic components of Polygoni Multiflori Radix and its processed products 多组学揭示何首乌及其制品的肝毒性机制和主要毒性成分。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-01-29 DOI: 10.1016/j.phymed.2026.157908
Qi Wu , Ziyi Chen , Zong Hou , Zhiqiang Liu , Rong Sun , Shu Liu

Background

Polygoni Multiflori Radix (PMR) and its processed form, Polygoni Multiflori Radix Praeparata (PMRP), are two widely used traditional Chinese medicines (TCM). However, in recent years, frequent reports have emerged regarding their hepatotoxicity. Despite numerous studies, the underlying mechanisms of hepatotoxicity and key toxic components remain poorly understood.

Purpose

This study aimed to comprehensively elucidate the hepatotoxic processes of PMR and PMRP and identify the principal toxic components.

Methods

In vivo toxicity tests were carried out to assess the toxicity levels and characteristics of PMR and PMRP. The integration of untargeted serum metabolomics, liver spatial transcriptomics, and liver spatial metabolomics was first employed to elucidate the toxicity mechanisms, which were further validated through metabolite and sensitive index levels and by evaluating protein expression. Mass spectrometry and cytotoxicity tests were utilised to determine the primary toxic components.

Results

The findings revealed that PMR and PMRP primarily regulate tryptophan metabolism, the tricarboxylic acid (TCA) cycle, purine metabolism, and glutathione metabolism. Furthermore, PMR and PMRP can inhibit the expression of bile acid transporters, causing obstruction of bile acid secretion. These modulations trigger oxidative stress, which subsequently leads to cholestasis. The accumulation of bile acids further intensifies oxidative stress, creating a vicious cycle. Furthermore, emodin was identified as the primary toxic component.

Conclusion

PMR and PMRP can induce cholestatic liver injury. They exert hepatotoxic effects by establishing a vicious cycle between cholestasis and oxidative stress, with emodin being the key component responsible for this toxicity.
背景:何首乌(PMR)及其炮制品何首乌(PMRP)是两种应用广泛的中药。然而,近年来,关于其肝毒性的报道频繁出现。尽管进行了大量的研究,但对肝毒性的潜在机制和关键毒性成分仍然知之甚少。目的:本研究旨在全面阐明PMR和PMRP的肝毒性过程,并确定其主要毒性成分。方法:采用体内毒性试验,评价PMR和PMRP的毒性水平和特性。非靶向血清代谢组学、肝脏空间转录组学和肝脏空间代谢组学的整合首次用于阐明毒性机制,并通过代谢物和敏感指数水平以及评估蛋白质表达进一步验证。采用质谱法和细胞毒性试验测定主要毒性成分。结果:PMR和PMRP主要调节色氨酸代谢、三羧酸(TCA)循环、嘌呤代谢和谷胱甘肽代谢。此外,PMR和PMRP可以抑制胆汁酸转运蛋白的表达,导致胆汁酸分泌受阻。这些调节触发氧化应激,随后导致胆汁淤积。胆汁酸的积累进一步加剧了氧化应激,形成恶性循环。此外,大黄素被鉴定为主要有毒成分。结论:PMR和PMRP可诱导胆汁淤积性肝损伤。它们通过在胆汁淤积和氧化应激之间建立恶性循环来发挥肝毒性作用,而大黄素是造成这种毒性的关键成分。
{"title":"Multi-omics reveals hepatotoxic mechanisms and key toxic components of Polygoni Multiflori Radix and its processed products","authors":"Qi Wu ,&nbsp;Ziyi Chen ,&nbsp;Zong Hou ,&nbsp;Zhiqiang Liu ,&nbsp;Rong Sun ,&nbsp;Shu Liu","doi":"10.1016/j.phymed.2026.157908","DOIUrl":"10.1016/j.phymed.2026.157908","url":null,"abstract":"<div><h3>Background</h3><div><em>Polygoni Multiflori Radix</em> (PMR) and its processed form, <em>Polygoni Multiflori Radix Praeparata</em> (PMRP), are two widely used traditional Chinese medicines (TCM). However, in recent years, frequent reports have emerged regarding their hepatotoxicity. Despite numerous studies, the underlying mechanisms of hepatotoxicity and key toxic components remain poorly understood.</div></div><div><h3>Purpose</h3><div>This study aimed to comprehensively elucidate the hepatotoxic processes of PMR and PMRP and identify the principal toxic components.</div></div><div><h3>Methods</h3><div><em>In vivo</em> toxicity tests were carried out to assess the toxicity levels and characteristics of PMR and PMRP. The integration of untargeted serum metabolomics, liver spatial transcriptomics, and liver spatial metabolomics was first employed to elucidate the toxicity mechanisms, which were further validated through metabolite and sensitive index levels and by evaluating protein expression. Mass spectrometry and cytotoxicity tests were utilised to determine the primary toxic components.</div></div><div><h3>Results</h3><div>The findings revealed that PMR and PMRP primarily regulate tryptophan metabolism, the tricarboxylic acid (TCA) cycle, purine metabolism, and glutathione metabolism. Furthermore, PMR and PMRP can inhibit the expression of bile acid transporters, causing obstruction of bile acid secretion. These modulations trigger oxidative stress, which subsequently leads to cholestasis. The accumulation of bile acids further intensifies oxidative stress, creating a vicious cycle. Furthermore, emodin was identified as the primary toxic component.</div></div><div><h3>Conclusion</h3><div>PMR and PMRP can induce cholestatic liver injury. They exert hepatotoxic effects by establishing a vicious cycle between cholestasis and oxidative stress, with emodin being the key component responsible for this toxicity.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157908"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Effusol ameliorates ischemic stroke by targeting NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis" [Phytomedicine, 136 (2025) 156253/PMID: 39615210]. “Effusol通过靶向NLRP3蛋白调控NLRP3炎症小体介导的焦亡来改善缺血性卒中”[植物医学],136 (2025):156253/PMID: 39615210]。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-02-23 DOI: 10.1016/j.phymed.2026.157968
Libin Xu, Siyu Li, Jiaxin Qi, Yan Mi, Ying Zhang, Yuxin Yang, Yingjie Wang, Di Zhou, Ning Li, Yue Hou
{"title":"Corrigendum to \"Effusol ameliorates ischemic stroke by targeting NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis\" [Phytomedicine, 136 (2025) 156253/PMID: 39615210].","authors":"Libin Xu, Siyu Li, Jiaxin Qi, Yan Mi, Ying Zhang, Yuxin Yang, Yingjie Wang, Di Zhou, Ning Li, Yue Hou","doi":"10.1016/j.phymed.2026.157968","DOIUrl":"10.1016/j.phymed.2026.157968","url":null,"abstract":"","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":" ","pages":"157968"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147284342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cordyceps cicadae polysaccharides ameliorate ulcerative colitis by modulating the gut microbiota and regulating the bile acid/FXR/NF-κB signaling pathway. 冬虫夏草多糖通过调节肠道菌群和胆汁酸/FXR/NF-κB信号通路改善溃疡性结肠炎。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-02-24 DOI: 10.1016/j.phymed.2026.158007
Siyu Zhou, Fayu Su, Qinhan Gao, Majie Wang, Jialin Duan, Jiankang Li
<p><strong>Background: </strong>Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease, closely linked to dysbiosis of the intestinal microbiota and abnormal bile acid homeostasis. Polysaccharides derived from Paecilomyces cicadae (CCP) exhibit immunomodulatory and anti-inflammatory effects. However, their therapeutic potential and underlying mechanisms in UC remain poorly elucidated.</p><p><strong>Purpose: </strong>This research seeks to evaluate the therapeutic efficacy of CCP in the treatment of UC and utilizing the "microbiota-bile acid metabolism-immunity" axis, elucidates the mechanisms by which CCP enhances intestinal barrier integrity and ameliorates inflammation via modulation of the gut microbiota-mediated farnesoid X receptor (FXR)/NF-κB signaling pathway.</p><p><strong>Methods: </strong>The physicochemical properties of CCP were characterized by FTIR spectroscopy, HPLC, and SEM analyses. A dextran sulfate sodium (DSS)-induced colitis mouse model was used to evaluate the ameliorative effects of CCP. Gut microbial alterations were profiled by 16S rDNA sequencing, while targeted metabolomics enabled comprehensive quantification of bile acid profiles in serum and fecal samples. Fecal microbiota transplantation (FMT) was conducted to validate the microbiota-mediated actions of CCP. Downstream molecular mechanisms were examined using Western blotting and immunofluorescence assays to assess modulation along the microbiota-bile acid axis.</p><p><strong>Results: </strong>CCP is primarily composed of glucose, mannose, and galactose, exhibiting a characteristic polysaccharide structure with a uniform molecular weight distribution. Treatment with CCP significantly ameliorated DSS-induced colitis in mice, as evidenced by reduced weight loss, preserved colon length, and decreased histopathological damage. 16S rDNA analysis demonstrated CCP-driven restoration of intestinal microbial diversity and a marked increase in Clostridium Kas107-2 (cluster XIVa). Metabolomics revealed normalization of bile acid metabolism, with elevated synthesis of secondary bile acids (deoxycholic acid, lithocholic acid, 12-keto LCA) and reduced levels of primary bile acids (α/β-MCA). Mechanistically, CCP activated FXR signaling, suppressed IκBα phosphorylation, downregulated NF-κB signaling, and reduced production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). Enhanced expression of tight junction proteins (ZO-1, Occludin, Claudin-1) indicated improved epithelial barrier function. Notably, FMT from CCP-treated donors replicated these protective effects, confirming colitis attenuation, bile acid restoration, and inhibition of FXR/NF-κB signaling.</p><p><strong>Conclusions: </strong>CCP ameliorate experimental UC by promoting the proliferation of Clostridium cluster XIVa, modulating bile acid metabolism to facilitate secondary bile acid biosynthesis, activating FXR pathways, and suppressing NF-κB-driven inflammatory responses, thereby reinforcing int
背景:溃疡性结肠炎(UC)是一种慢性、复发性炎症性肠病,与肠道菌群失调和胆汁酸稳态异常密切相关。蝉拟青霉(Paecilomyces cicadae, CCP)多糖具有免疫调节和抗炎作用。然而,它们在UC中的治疗潜力和潜在机制仍不清楚。目的:本研究旨在评价CCP治疗UC的疗效,并利用“微生物-胆汁酸代谢-免疫”轴,阐明CCP通过调节肠道微生物介导的法内甾体X受体(FXR)/NF-κB信号通路增强肠道屏障完整性和改善炎症的机制。方法:采用FTIR、HPLC、SEM等方法对CCP的理化性质进行表征。采用葡聚糖硫酸钠(DSS)诱导结肠炎小鼠模型,评价CCP对结肠炎小鼠的改善作用。通过16S rDNA测序分析肠道微生物变化,而靶向代谢组学可以全面量化血清和粪便样本中的胆汁酸谱。通过粪便菌群移植(FMT)验证菌群介导CCP的作用。下游分子机制通过Western blotting和免疫荧光检测来评估沿微生物-胆汁酸轴的调节。结果:CCP主要由葡萄糖、甘露糖和半乳糖组成,具有分子量分布均匀的多糖结构特征。CCP治疗可显著改善dss诱导的小鼠结肠炎,表现为体重减轻、结肠长度保持和组织病理学损伤减少。16S rDNA分析显示ccp驱动的肠道微生物多样性恢复和Clostridium Kas107-2 (cluster XIVa)的显著增加。代谢组学显示胆汁酸代谢正常化,次级胆汁酸(脱氧胆酸、石胆酸、12-酮LCA)合成升高,初级胆汁酸(α/β-MCA)水平降低。机制上,CCP激活FXR信号,抑制i -κB α磷酸化,下调NF-κB信号,减少促炎细胞因子(TNF-α、IL-1β、IL-6)的产生。紧密连接蛋白(ZO-1, Occludin, Claudin-1)的表达增强表明上皮屏障功能得到改善。值得注意的是,来自ccp处理供体的FMT复制了这些保护作用,证实了结肠炎的衰减、胆汁酸的恢复和FXR/NF-κB信号的抑制。结论:CCP通过促进XIVa梭菌群增殖,调节胆汁酸代谢促进二次胆汁酸生物合成,激活FXR通路,抑制NF-κ b驱动的炎症反应,从而增强肠上皮屏障的完整性,改善实验性UC。
{"title":"Cordyceps cicadae polysaccharides ameliorate ulcerative colitis by modulating the gut microbiota and regulating the bile acid/FXR/NF-κB signaling pathway.","authors":"Siyu Zhou, Fayu Su, Qinhan Gao, Majie Wang, Jialin Duan, Jiankang Li","doi":"10.1016/j.phymed.2026.158007","DOIUrl":"10.1016/j.phymed.2026.158007","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease, closely linked to dysbiosis of the intestinal microbiota and abnormal bile acid homeostasis. Polysaccharides derived from Paecilomyces cicadae (CCP) exhibit immunomodulatory and anti-inflammatory effects. However, their therapeutic potential and underlying mechanisms in UC remain poorly elucidated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;This research seeks to evaluate the therapeutic efficacy of CCP in the treatment of UC and utilizing the \"microbiota-bile acid metabolism-immunity\" axis, elucidates the mechanisms by which CCP enhances intestinal barrier integrity and ameliorates inflammation via modulation of the gut microbiota-mediated farnesoid X receptor (FXR)/NF-κB signaling pathway.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The physicochemical properties of CCP were characterized by FTIR spectroscopy, HPLC, and SEM analyses. A dextran sulfate sodium (DSS)-induced colitis mouse model was used to evaluate the ameliorative effects of CCP. Gut microbial alterations were profiled by 16S rDNA sequencing, while targeted metabolomics enabled comprehensive quantification of bile acid profiles in serum and fecal samples. Fecal microbiota transplantation (FMT) was conducted to validate the microbiota-mediated actions of CCP. Downstream molecular mechanisms were examined using Western blotting and immunofluorescence assays to assess modulation along the microbiota-bile acid axis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;CCP is primarily composed of glucose, mannose, and galactose, exhibiting a characteristic polysaccharide structure with a uniform molecular weight distribution. Treatment with CCP significantly ameliorated DSS-induced colitis in mice, as evidenced by reduced weight loss, preserved colon length, and decreased histopathological damage. 16S rDNA analysis demonstrated CCP-driven restoration of intestinal microbial diversity and a marked increase in Clostridium Kas107-2 (cluster XIVa). Metabolomics revealed normalization of bile acid metabolism, with elevated synthesis of secondary bile acids (deoxycholic acid, lithocholic acid, 12-keto LCA) and reduced levels of primary bile acids (α/β-MCA). Mechanistically, CCP activated FXR signaling, suppressed IκBα phosphorylation, downregulated NF-κB signaling, and reduced production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). Enhanced expression of tight junction proteins (ZO-1, Occludin, Claudin-1) indicated improved epithelial barrier function. Notably, FMT from CCP-treated donors replicated these protective effects, confirming colitis attenuation, bile acid restoration, and inhibition of FXR/NF-κB signaling.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;CCP ameliorate experimental UC by promoting the proliferation of Clostridium cluster XIVa, modulating bile acid metabolism to facilitate secondary bile acid biosynthesis, activating FXR pathways, and suppressing NF-κB-driven inflammatory responses, thereby reinforcing int","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"158007"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147322173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Semen Sojae Praeparatum ameliorates triptolide-induced liver injury by regulating bile acid homeostasis and the Keap1/Nrf2/p62 axis 黄豆精通过调节胆酸稳态和Keap1/Nrf2/p62轴改善雷公藤甲素诱导的肝损伤
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-01-22 DOI: 10.1016/j.phymed.2026.157878
Lin Zhou , Qi Qian , Yaqin Zhen , Hanyu Ma , Liying Niu , Xinguo Wang

Background

Semen Sojae Praeparatum (SSP) exhibits both preventive and therapeutic effects against drug-induced liver injury (DILI). Traditionally, SSP is used in combination with Gardeniae fructus to prevent its hepatotoxicity. Isoflavones, the primary components of SSP, can mitigate DILI induced by chemotherapeutic agents such as acetaminophen and cisplatin. However, the potential of SSP to alleviate the hepatotoxicity of triptolide (TP, a prototypical compound in DILI research) remains unexplored.

Purpose

This study aimed to explore the protective effects and potential mechanisms of SSP on TP-induced liver injury.

Methods

The phytochemical profile of the SSP extracts was characterized using UPLC-Q-TOF-MS. Hepatoprotective effects of SSP were assessed using a TP-induced liver injury mouse model. The mechanisms were predicted by metabolomic and proteomic analyses, and further elucidated by RT-qPCR, western blotting and transmission electron microscopy.

Results

Isoflavones were identified as the main components of the SSP extracts. SSP treatment alleviated TP-induced abnormalities in serum biochemical markers, liver index and pathological damage. Multi-omics analysis revealed SSP modulated bile acid (BA) metabolism and autophagy, with Keap1 serving as a core protein. Furthermore, SSP reduced intrahepatic BA accumulation by enhancing hepatic BA transport rather than inhibiting BA synthesis. Additionally, SSP reversed TP-induced abnormalities in Keap1 and p62 expression and nuclear translon cation of the Nrf2 transcription factor, and mitigated oxidative imbalance and autophagic cell death.

Conclusions

SSP ameliorated TP-induced liver injury by modulating bile acid homeostasis and the Keap1/Nrf2/p62 pathway, thereby alleviating oxidative stress and excessive autophagy.
黄豆精(SSP)对药物性肝损伤(DILI)具有预防和治疗双重作用。传统上,SSP与栀子联合使用,以防止其肝毒性。SSP的主要成分异黄酮可以减轻对乙酰氨基酚和顺铂等化疗药物引起的DILI。然而,SSP减轻雷公藤甲素(TP, DILI研究中的一种典型化合物)肝毒性的潜力仍未被探索。目的探讨SSP对tp性肝损伤的保护作用及其可能机制。方法采用UPLC-Q-TOF-MS对SSP提取物的植物化学特征进行表征。采用tp诱导的肝损伤小鼠模型,评估了SSP的肝保护作用。通过代谢组学和蛋白质组学分析预测了其机制,并通过RT-qPCR、western blotting和透射电镜进一步阐明了其机制。结果黄芪提取物的主要成分为异黄酮。SSP治疗可减轻tp引起的血清生化指标、肝脏指数异常及病理损伤。多组学分析显示,SSP调节胆汁酸(BA)代谢和自噬,其中Keap1是核心蛋白。此外,SSP通过增强肝脏BA转运而不是抑制BA合成来减少肝内BA积累。此外,SSP逆转了tp诱导的Keap1和p62表达异常以及Nrf2转录因子的核翻译阳离子,减轻了氧化失衡和自噬细胞死亡。结论sssp通过调节胆胆酸稳态和Keap1/Nrf2/p62通路改善tp诱导的肝损伤,从而减轻氧化应激和过度自噬。
{"title":"Semen Sojae Praeparatum ameliorates triptolide-induced liver injury by regulating bile acid homeostasis and the Keap1/Nrf2/p62 axis","authors":"Lin Zhou ,&nbsp;Qi Qian ,&nbsp;Yaqin Zhen ,&nbsp;Hanyu Ma ,&nbsp;Liying Niu ,&nbsp;Xinguo Wang","doi":"10.1016/j.phymed.2026.157878","DOIUrl":"10.1016/j.phymed.2026.157878","url":null,"abstract":"<div><h3>Background</h3><div>Semen Sojae Praeparatum (SSP) exhibits both preventive and therapeutic effects against drug-induced liver injury (DILI). Traditionally, SSP is used in combination with <em>Gardeniae fructus</em> to prevent its hepatotoxicity. Isoflavones, the primary components of SSP, can mitigate DILI induced by chemotherapeutic agents such as acetaminophen and cisplatin. However, the potential of SSP to alleviate the hepatotoxicity of triptolide (TP, a prototypical compound in DILI research) remains unexplored.</div></div><div><h3>Purpose</h3><div>This study aimed to explore the protective effects and potential mechanisms of SSP on TP-induced liver injury.</div></div><div><h3>Methods</h3><div>The phytochemical profile of the SSP extracts was characterized using UPLC-Q-TOF-MS. Hepatoprotective effects of SSP were assessed using a TP-induced liver injury mouse model. The mechanisms were predicted by metabolomic and proteomic analyses, and further elucidated by RT-qPCR, western blotting and transmission electron microscopy.</div></div><div><h3>Results</h3><div>Isoflavones were identified as the main components of the SSP extracts. SSP treatment alleviated TP-induced abnormalities in serum biochemical markers, liver index and pathological damage. Multi-omics analysis revealed SSP modulated bile acid (BA) metabolism and autophagy, with Keap1 serving as a core protein. Furthermore, SSP reduced intrahepatic BA accumulation by enhancing hepatic BA transport rather than inhibiting BA synthesis. Additionally, SSP reversed TP-induced abnormalities in Keap1 and p62 expression and nuclear translon cation of the Nrf2 transcription factor, and mitigated oxidative imbalance and autophagic cell death.</div></div><div><h3>Conclusions</h3><div>SSP ameliorated TP-induced liver injury by modulating bile acid homeostasis and the Keap1/Nrf2/p62 pathway, thereby alleviating oxidative stress and excessive autophagy.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157878"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146192028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curcumol targets the ATG4B–PKM2–lactate signaling axis to reverse EMT and inhibit colorectal cancer liver metastasis Curcumol靶向ATG4B-PKM2-lactate信号轴逆转EMT,抑制结直肠癌肝转移
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-02-07 DOI: 10.1016/j.phymed.2026.157933
Gang Wang , Zengyaran Yue , Wen Zhou , Cong Peng , Tingting Bi , Xiying Tan , Weiwei He , Yuwei Zhang , Zhuo Deng , Danning Zhang , Wenhao Yuan , Yong Bian , Gang Yin , Lifeng Zhu , Decai Tang

Background

Distant metastasis of colorectal cancer (CRC) is strongly driven by metabolic reprogramming and epithelial–mesenchymal transition (EMT). Increasing evidence suggests that these two processes form a reinforcing positive feedback loop; however, the integrated regulatory mechanism and its potential for pharmacological intervention remain insufficiently understood.

Objective

This study aimed to elucidate the mechanistic coupling between autophagy, metabolic reprogramming, and EMT, and to develop a targeted pharmacological strategy capable of disrupting this positive feedback loop.

Study Design

We systematically constructed and validated an autophagy–metabolism–phenotypic transformation regulatory axis centered on ATG4B and PKM2, and evaluated the therapeutic efficacy of Curcumol as a pathway-specific natural compound intervention.

Methods

Biochemical assays, protein–protein interaction analyses, and functional experiments were performed to determine how ATG4B regulates PKM2 Tyr105 phosphorylation, nuclear translocation, and glycolytic activity. Curcumol was applied to assess its ability to activate ATG4B-dependent autophagy and inhibit PKM2 activation. Anti-tumor efficacy was validated using colorectal cancer organoids, orthotopic implantation, and liver metastasis mouse models.

Results

ATG4B was identified as a core autophagy enzyme that directly binds to and shields the PKM2 Tyr105 site, preventing FGFR1-mediated phosphorylation and nuclear translocation. This blockade suppressed the Warburg effect, reduced lactate production, and synergistically inhibited EMT progression. Curcumol activated ATG4B-dependent autophagy, inhibited PKM2 activation, and effectively disrupted the metabolism–EMT positive feedback loop. In multiple CRC models, Curcumol markedly suppressed tumor growth and metastasis, supporting its therapeutic potential.

Conclusion

This study reveals the ATG4B–PKM2 axis as a critical regulatory node linking autophagy, metabolic reprogramming, and EMT. Targeting this axis with Curcumol provides a precise strategy to interrupt metabolism–phenotype coupling, offering a mechanistically grounded and translationally promising approach for inhibiting CRC progression and metastasis.
结直肠癌(CRC)的远处转移是由代谢重编程和上皮-间质转化(EMT)强烈驱动的。越来越多的证据表明,这两个过程形成了一个不断强化的正反馈循环;然而,综合调控机制及其潜在的药理学干预仍不充分了解。目的本研究旨在阐明自噬、代谢重编程和EMT之间的机制耦合,并开发一种能够破坏这种正反馈循环的靶向药物策略。研究设计我们系统构建并验证了以ATG4B和PKM2为中心的自噬-代谢-表型转化调控轴,并评估莪术醇作为途径特异性天然化合物干预的治疗效果。方法通过生化分析、蛋白相互作用分析和功能实验来确定ATG4B如何调节PKM2 Tyr105磷酸化、核易位和糖酵解活性。莪术醇用于评估其激活atg4b依赖性自噬和抑制PKM2激活的能力。通过结肠直肠癌类器官、原位植入和肝转移小鼠模型验证了其抗肿瘤功效。结果satg4b被鉴定为一种核心自噬酶,直接结合并屏蔽PKM2 Tyr105位点,阻止fgfr1介导的磷酸化和核易位。这种阻断抑制了Warburg效应,减少了乳酸的产生,并协同抑制了EMT的进展。Curcumol激活atg4b依赖性自噬,抑制PKM2激活,有效破坏代谢- emt正反馈回路。在多种结直肠癌模型中,莪术醇显著抑制肿瘤生长和转移,支持其治疗潜力。结论ATG4B-PKM2轴是连接自噬、代谢重编程和EMT的关键调控节点。Curcumol靶向该轴提供了一种精确的策略来中断代谢-表型耦合,为抑制结直肠癌的进展和转移提供了一种机制基础和翻译前景良好的方法。
{"title":"Curcumol targets the ATG4B–PKM2–lactate signaling axis to reverse EMT and inhibit colorectal cancer liver metastasis","authors":"Gang Wang ,&nbsp;Zengyaran Yue ,&nbsp;Wen Zhou ,&nbsp;Cong Peng ,&nbsp;Tingting Bi ,&nbsp;Xiying Tan ,&nbsp;Weiwei He ,&nbsp;Yuwei Zhang ,&nbsp;Zhuo Deng ,&nbsp;Danning Zhang ,&nbsp;Wenhao Yuan ,&nbsp;Yong Bian ,&nbsp;Gang Yin ,&nbsp;Lifeng Zhu ,&nbsp;Decai Tang","doi":"10.1016/j.phymed.2026.157933","DOIUrl":"10.1016/j.phymed.2026.157933","url":null,"abstract":"<div><h3>Background</h3><div>Distant metastasis of colorectal cancer (CRC) is strongly driven by metabolic reprogramming and epithelial–mesenchymal transition (EMT). Increasing evidence suggests that these two processes form a reinforcing positive feedback loop; however, the integrated regulatory mechanism and its potential for pharmacological intervention remain insufficiently understood.</div></div><div><h3>Objective</h3><div>This study aimed to elucidate the mechanistic coupling between autophagy, metabolic reprogramming, and EMT, and to develop a targeted pharmacological strategy capable of disrupting this positive feedback loop.</div></div><div><h3>Study Design</h3><div>We systematically constructed and validated an autophagy–metabolism–phenotypic transformation regulatory axis centered on ATG4B and PKM2, and evaluated the therapeutic efficacy of Curcumol as a pathway-specific natural compound intervention.</div></div><div><h3>Methods</h3><div>Biochemical assays, protein–protein interaction analyses, and functional experiments were performed to determine how ATG4B regulates PKM2 Tyr105 phosphorylation, nuclear translocation, and glycolytic activity. Curcumol was applied to assess its ability to activate ATG4B-dependent autophagy and inhibit PKM2 activation. Anti-tumor efficacy was validated using colorectal cancer organoids, orthotopic implantation, and liver metastasis mouse models.</div></div><div><h3>Results</h3><div>ATG4B was identified as a core autophagy enzyme that directly binds to and shields the PKM2 Tyr105 site, preventing FGFR1-mediated phosphorylation and nuclear translocation. This blockade suppressed the Warburg effect, reduced lactate production, and synergistically inhibited EMT progression. Curcumol activated ATG4B-dependent autophagy, inhibited PKM2 activation, and effectively disrupted the metabolism–EMT positive feedback loop. In multiple CRC models, Curcumol markedly suppressed tumor growth and metastasis, supporting its therapeutic potential.</div></div><div><h3>Conclusion</h3><div>This study reveals the ATG4B–PKM2 axis as a critical regulatory node linking autophagy, metabolic reprogramming, and EMT. Targeting this axis with Curcumol provides a precise strategy to interrupt metabolism–phenotype coupling, offering a mechanistically grounded and translationally promising approach for inhibiting CRC progression and metastasis.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157933"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146192292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dehydrocavidine alleviates lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway to inhibit hepatocyte ferroptosis 脱氢卡维啶通过激活Nrf2信号通路抑制肝细胞铁凋亡,减轻脂多糖诱导的急性肝损伤。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-01-17 DOI: 10.1016/j.phymed.2026.157845
Hongbiao Liang , Guizimeng Hu , Dongmin Yang , Yuwei Song , Peng Zhang , Tianqi Chen , Xiangrui Zhu , Peiyi Li , Yuan Wang , Xinmei Huo , Xiaoyi Wang , Yi Zhang , Yujie Zhang , Jian Liu , Juan Feng

Background

Sepsis-induced acute liver injury (SALI) remains a major challenge with limited effective treatments. Although Corydalis saxicola Bunting (CSB) exhibits anti-inflammatory and hepatoprotective properties, its role in SALI remains poorly understood.

Purpose

To identify the active components and molecular mechanisms of CSB in protecting against SALI.

Methods

In vivo LPS-induced rat liver injury and in vitro cytokine-induced HepG2 injury models were established, treated with CSB extract or dehydrocavidine (DC). A series of advanced techniques including ferroptosis PCR array, super-resolution stimulated emission depletion (STED) microscopy, assay for transposase-accessible chromatin with sequencing (ATAC-seq), cellular thermal shift assay (CETSA), surface plasmon resonance (SPR), molecular dynamics simulation, and site-directed mutation were employed to investigate the underlying mechanisms.

Results

DC significantly mitigated LPS-induced liver injury, microcirculatory disorder, and leukocyte adhesion. It also alleviated liver ferroptosis under LPS challenge. In vitro studies revealed that LPS-activated macrophages secreted tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ), which triggered hepatocyte ferroptosis. DC countered this process by inhibiting the production of these cytokines and correcting cytokine-induced mitochondrial abnormalities in hepatocytes. Mechanistically, DC bound to Kelch-like ECH-associated protein 1 (Keap1) at arginine 415 (R415), disrupting the formation of the Keap1/nuclear factor erythroid 2-related factor 2 (Nrf2) complex. This enabled Nrf2 nuclear translocation and promoted antioxidant gene expression, thereby correcting LPS-induced redox imbalance in hepatocytes.

Conclusions

In addition to inhibiting LPS-induced macrophage activation, DC activates the Nrf2 signaling pathway in hepatocytes to alleviate inflammation-enhanced liver ferroptosis. It provides potential therapeutic strategies for sepsis and Gram-negative bacteria-associated liver injury.
背景:脓毒症引起的急性肝损伤(SALI)仍然是一个主要的挑战,有效的治疗方法有限。虽然紫连珠(CSB)具有抗炎和保护肝脏的特性,但其在SALI中的作用仍然知之甚少。目的:研究CSB抗SALI的活性成分及分子机制。方法:建立lps诱导的大鼠肝损伤模型和体外细胞因子诱导的HepG2损伤模型,分别给予CSB提取物或脱氢卡维啶(DC)处理。采用了一系列先进的技术,包括铁凋亡PCR阵列,超分辨率受激发射损耗(STED)显微镜,转座酶可及染色质测序(ATAC-seq),细胞热移测定(CETSA),表面等离子体共振(SPR),分子动力学模拟和位点定向突变来研究其潜在的机制。结果:DC显著减轻lps诱导的肝损伤、微循环障碍和白细胞粘附。它还能减轻LPS刺激下的肝脏铁下垂。体外研究发现,lps激活的巨噬细胞分泌肿瘤坏死因子-α (TNF-α)和干扰素-γ (IFN-γ),引发肝细胞铁下垂。DC通过抑制这些细胞因子的产生和纠正肝细胞中细胞因子诱导的线粒体异常来对抗这一过程。从机制上讲,DC在精氨酸415 (R415)处与kelch样ech相关蛋白1 (Keap1)结合,破坏Keap1/核因子红系2相关因子2 (Nrf2)复合物的形成。这使得Nrf2核易位,促进抗氧化基因表达,从而纠正脂多糖诱导的肝细胞氧化还原失衡。结论:DC除抑制lps诱导的巨噬细胞活化外,还激活肝细胞Nrf2信号通路,减轻炎症增强的肝铁下垂。它为败血症和革兰氏阴性菌相关肝损伤提供了潜在的治疗策略。
{"title":"Dehydrocavidine alleviates lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway to inhibit hepatocyte ferroptosis","authors":"Hongbiao Liang ,&nbsp;Guizimeng Hu ,&nbsp;Dongmin Yang ,&nbsp;Yuwei Song ,&nbsp;Peng Zhang ,&nbsp;Tianqi Chen ,&nbsp;Xiangrui Zhu ,&nbsp;Peiyi Li ,&nbsp;Yuan Wang ,&nbsp;Xinmei Huo ,&nbsp;Xiaoyi Wang ,&nbsp;Yi Zhang ,&nbsp;Yujie Zhang ,&nbsp;Jian Liu ,&nbsp;Juan Feng","doi":"10.1016/j.phymed.2026.157845","DOIUrl":"10.1016/j.phymed.2026.157845","url":null,"abstract":"<div><h3>Background</h3><div>Sepsis-induced acute liver injury (SALI) remains a major challenge with limited effective treatments. Although Corydalis saxicola Bunting (CSB) exhibits anti-inflammatory and hepatoprotective properties, its role in SALI remains poorly understood.</div></div><div><h3>Purpose</h3><div>To identify the active components and molecular mechanisms of CSB in protecting against SALI.</div></div><div><h3>Methods</h3><div><em>In vivo</em> LPS-induced rat liver injury and <em>in vitro</em> cytokine-induced HepG2 injury models were established, treated with CSB extract or dehydrocavidine (DC). A series of advanced techniques including ferroptosis PCR array, super-resolution stimulated emission depletion (STED) microscopy, assay for transposase-accessible chromatin with sequencing (ATAC-seq), cellular thermal shift assay (CETSA), surface plasmon resonance (SPR), molecular dynamics simulation, and site-directed mutation were employed to investigate the underlying mechanisms.</div></div><div><h3>Results</h3><div>DC significantly mitigated LPS-induced liver injury, microcirculatory disorder, and leukocyte adhesion. It also alleviated liver ferroptosis under LPS challenge. <em>In vitro</em> studies revealed that LPS-activated macrophages secreted tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ), which triggered hepatocyte ferroptosis. DC countered this process by inhibiting the production of these cytokines and correcting cytokine-induced mitochondrial abnormalities in hepatocytes. Mechanistically, DC bound to Kelch-like ECH-associated protein 1 (Keap1) at arginine 415 (R415), disrupting the formation of the Keap1/nuclear factor erythroid 2-related factor 2 (Nrf2) complex. This enabled Nrf2 nuclear translocation and promoted antioxidant gene expression, thereby correcting LPS-induced redox imbalance in hepatocytes.</div></div><div><h3>Conclusions</h3><div>In addition to inhibiting LPS-induced macrophage activation, DC activates the Nrf2 signaling pathway in hepatocytes to alleviate inflammation-enhanced liver ferroptosis. It provides potential therapeutic strategies for sepsis and Gram-negative bacteria-associated liver injury.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157845"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aloesin improves metabolic associated fatty liver disease and obesity by targeting TGFBR1 芦荟素通过靶向TGFBR1改善代谢相关的脂肪肝疾病和肥胖。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-02-05 DOI: 10.1016/j.phymed.2026.157922
Jianfeng Wu , Siqi Liu , Zhen Ma , Badrakh Munkhbayar , Qichao Liao , Menglong Hou , Yutian Wei , Yang Xiao , Yang Wang , Ruxue Chen , Batbold Batsaikhan , Khongorzul Batchuluun , Lei Zhou , Yixing Li

Background

Metabolic associated fatty liver disease (MAFLD) is a chronic liver condition with a high global prevalence. Obesity and its associated insulin resistance are among the main risk factors for MAFLD, for which no effective clinical treatments are currently available. Aloesin, a natural chromone compound derived from Aloe vera, has anti-inflammatory, antioxidant, anticancer, and antidiabetes activity. However, its involvement in MAFLD has not been systematically studied.

Purpose

This study investigated the effectiveness of aloesin against MAFLD and obesity and elucidated its potential molecular mechanism.

Methods

Aloesin was added to the high-fat diet-of an induced mouse model and to oleic acid/palmitic acid-induced HepG2 cells to explore its effect on lipid metabolism. Molecular targets were identified by reverse docking, cellular thermal shift assay (CETSA), and drug affinity responsive target stability (DARTS).

Results

Aloesin significantly reduced lipid accumulation in hepatocytes in both the high-fat diet-induced MAFLD mouse model and the oleic acid/palmitic acid-induced HepG2 cells. It also alleviated oxidative stress and energy metabolism disorders and decreased the body fat mass in mice fed the high-fat diet, which ameliorated the pathological features of MAFLD and obesity. Target prediction and validation identified TGFBR1 as a direct target of aloesin, which was confirmed by CETSA and DARTS. Functional experiments demonstrated that overexpression of TGFBR1 increased lipid accumulation and metabolic disturbances, which were reversed by aloesin.

Conclusion

Aloesin improved lipid deposition and slowed the progression of MAFLD by targeting TGFBR1. The results support its potential application for the prevention and treatment of MAFLD.
背景:代谢性相关脂肪性肝病(MAFLD)是一种全球高发的慢性肝病。肥胖及其相关的胰岛素抵抗是MAFLD的主要危险因素之一,目前尚无有效的临床治疗方法。芦荟素是一种从芦荟中提取的天然色素化合物,具有抗炎、抗氧化、抗癌和抗糖尿病的活性。然而,它在MAFLD中的作用尚未得到系统的研究。目的:研究芦荟素对糖尿病和肥胖症的治疗作用,并探讨其潜在的分子机制。方法:将芦荟素添加到高脂肪小鼠模型和油酸/棕榈酸诱导的HepG2细胞中,探讨其对脂质代谢的影响。通过反向对接、细胞热移测定(CETSA)和药物亲和反应靶稳定性(DARTS)鉴定分子靶标。结果:芦荟素在高脂饮食诱导的MAFLD小鼠模型和油酸/棕榈酸诱导的HepG2细胞中均能显著降低肝细胞中的脂质积累。还可减轻高脂饮食小鼠的氧化应激和能量代谢紊乱,降低体脂量,从而改善MAFLD和肥胖的病理特征。靶标预测和验证证实TGFBR1是芦荟素的直接靶标,并通过CETSA和dart得到证实。功能实验表明,TGFBR1的过表达增加了脂质积累和代谢紊乱,芦荟素可以逆转这一过程。结论:芦荟素可通过靶向TGFBR1改善mld的脂质沉积,减缓mld的进展。结果支持其在预防和治疗mald方面的潜在应用。
{"title":"Aloesin improves metabolic associated fatty liver disease and obesity by targeting TGFBR1","authors":"Jianfeng Wu ,&nbsp;Siqi Liu ,&nbsp;Zhen Ma ,&nbsp;Badrakh Munkhbayar ,&nbsp;Qichao Liao ,&nbsp;Menglong Hou ,&nbsp;Yutian Wei ,&nbsp;Yang Xiao ,&nbsp;Yang Wang ,&nbsp;Ruxue Chen ,&nbsp;Batbold Batsaikhan ,&nbsp;Khongorzul Batchuluun ,&nbsp;Lei Zhou ,&nbsp;Yixing Li","doi":"10.1016/j.phymed.2026.157922","DOIUrl":"10.1016/j.phymed.2026.157922","url":null,"abstract":"<div><h3>Background</h3><div>Metabolic associated fatty liver disease (MAFLD) is a chronic liver condition with a high global prevalence. Obesity and its associated insulin resistance are among the main risk factors for MAFLD, for which no effective clinical treatments are currently available. Aloesin, a natural chromone compound derived from <em>Aloe vera,</em> has anti-inflammatory, antioxidant, anticancer, and antidiabetes activity. However, its involvement in MAFLD has not been systematically studied.</div></div><div><h3>Purpose</h3><div>This study investigated the effectiveness of aloesin against MAFLD and obesity and elucidated its potential molecular mechanism.</div></div><div><h3>Methods</h3><div>Aloesin was added to the high-fat diet-of an induced mouse model and to oleic acid/palmitic acid-induced HepG2 cells to explore its effect on lipid metabolism. Molecular targets were identified by reverse docking, cellular thermal shift assay (CETSA), and drug affinity responsive target stability (DARTS).</div></div><div><h3>Results</h3><div>Aloesin significantly reduced lipid accumulation in hepatocytes in both the high-fat diet-induced MAFLD mouse model and the oleic acid/palmitic acid-induced HepG2 cells. It also alleviated oxidative stress and energy metabolism disorders and decreased the body fat mass in mice fed the high-fat diet, which ameliorated the pathological features of MAFLD and obesity. Target prediction and validation identified TGFBR1 as a direct target of aloesin, which was confirmed by CETSA and DARTS. Functional experiments demonstrated that overexpression of TGFBR1 increased lipid accumulation and metabolic disturbances, which were reversed by aloesin.</div></div><div><h3>Conclusion</h3><div>Aloesin improved lipid deposition and slowed the progression of MAFLD by targeting TGFBR1. The results support its potential application for the prevention and treatment of MAFLD.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157922"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146181918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rewiring the regulated cell death network in diabetic retinopathy: natural products as system-level modulators 糖尿病视网膜病变中受调节的细胞死亡网络的重新布线:作为系统级调节剂的天然产物。
IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-04-01 Epub Date: 2026-01-16 DOI: 10.1016/j.phymed.2026.157844
Qun Huang , Tingru Chen , Fang Wang , Jieying Wang , Biying Fan , Ruolan Wu , Jinlian Wang , Shunlin Peng , Yanlin Zheng

Background

Diabetic retinopathy (DR) pathogenesis is driven by the dysregulation of an interconnected network of regulated cell death (RCD) modalities, including apoptosis, autophagy-dependent cell death, pyroptosis, and ferroptosis. Current therapies often fail to address this upstream cellular damage. Natural products (NPs), with their inherent polypharmacology, offer a promising strategy to modulate this complex network.

Purpose

This review advances a framework conceptualizing DR as the collapse of a dynamic RCD network and positions NPs as "RCD network modulators". We delineate how these agents can restore homeostasis and overcome the limitations of existing mono-target therapies.

Methods

A systematic literature search was conducted using Web of Science and PubMed, integrating keywords related to "natural products", "diabetic retinopathy", and specific "regulated cell death" modalities. All animal experiments adhered to ethical guidelines and complied with both international and institutional ethical standards.

Results

NPs simultaneously engage the master regulatory nodes—mitochondrial dysfunction, hyperactivation of the inflammasome, and oxidative stress. By modulating the Bcl-2 rheostat, normalizing autophagic flux, suppressing NLRP3 assembly, and activating Nrf2/SIRT1 pathways, NPs orchestrate a "network rewiring" to halt DR progression. However, clinical translation is significantly constrained by pharmacokinetic challenges, including low oral bioavailability and poor ocular penetration.

Conclusion

DR pathology emerges from network-level RCD dysregulation. NPs, which function as modulators of the RCD network, represent a compelling therapeutic shift toward addressing the root drivers of retinal degeneration.
背景:糖尿病视网膜病变(DR)的发病机制是由一个相互关联的细胞死亡(RCD)模式网络的失调驱动的,包括细胞凋亡、自噬依赖性细胞死亡、焦亡和铁亡。目前的治疗方法往往不能解决这种上游细胞损伤。天然产物(NPs)以其固有的多药理学,为调节这一复杂网络提供了一种有前途的策略。目的:本文提出了一个框架,将DR概念化为动态RCD网络的崩溃,并将NPs定位为“RCD网络调制器”。我们描述了这些药物如何恢复体内平衡并克服现有单靶点治疗的局限性。方法:利用Web of Science和PubMed进行系统文献检索,整合“天然产物”、“糖尿病视网膜病变”和特定“调节细胞死亡”方式等相关关键词。所有动物实验均遵循伦理准则,符合国际和机构的伦理标准。结果:NPs同时参与主要调控节点——线粒体功能障碍、炎性体过度激活和氧化应激。通过调节Bcl-2变阻器,使自噬通量正常化,抑制NLRP3组装,激活Nrf2/SIRT1通路,NPs协调“网络重新布线”以阻止DR进展。然而,临床翻译明显受到药代动力学挑战的限制,包括口服生物利用度低和眼穿透性差。结论:网络水平的RCD失调导致了DR病理。NPs作为RCD网络的调节剂,代表了一个引人注目的治疗转变,以解决视网膜变性的根本驱动因素。
{"title":"Rewiring the regulated cell death network in diabetic retinopathy: natural products as system-level modulators","authors":"Qun Huang ,&nbsp;Tingru Chen ,&nbsp;Fang Wang ,&nbsp;Jieying Wang ,&nbsp;Biying Fan ,&nbsp;Ruolan Wu ,&nbsp;Jinlian Wang ,&nbsp;Shunlin Peng ,&nbsp;Yanlin Zheng","doi":"10.1016/j.phymed.2026.157844","DOIUrl":"10.1016/j.phymed.2026.157844","url":null,"abstract":"<div><h3>Background</h3><div>Diabetic retinopathy (DR) pathogenesis is driven by the dysregulation of an interconnected network of regulated cell death (RCD) modalities, including apoptosis, autophagy-dependent cell death, pyroptosis, and ferroptosis. Current therapies often fail to address this upstream cellular damage. Natural products (NPs), with their inherent polypharmacology, offer a promising strategy to modulate this complex network.</div></div><div><h3>Purpose</h3><div>This review advances a framework conceptualizing DR as the collapse of a dynamic RCD network and positions NPs as \"RCD network modulators\". We delineate how these agents can restore homeostasis and overcome the limitations of existing mono-target therapies.</div></div><div><h3>Methods</h3><div>A systematic literature search was conducted using Web of Science and PubMed, integrating keywords related to \"natural products\", \"diabetic retinopathy\", and specific \"regulated cell death\" modalities. All animal experiments adhered to ethical guidelines and complied with both international and institutional ethical standards.</div></div><div><h3>Results</h3><div>NPs simultaneously engage the master regulatory nodes—mitochondrial dysfunction, hyperactivation of the inflammasome, and oxidative stress. By modulating the Bcl-2 rheostat, normalizing autophagic flux, suppressing NLRP3 assembly, and activating Nrf2/SIRT1 pathways, NPs orchestrate a \"network rewiring\" to halt DR progression. However, clinical translation is significantly constrained by pharmacokinetic challenges, including low oral bioavailability and poor ocular penetration.</div></div><div><h3>Conclusion</h3><div>DR pathology emerges from network-level RCD dysregulation. NPs, which function as modulators of the RCD network, represent a compelling therapeutic shift toward addressing the root drivers of retinal degeneration.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"153 ","pages":"Article 157844"},"PeriodicalIF":8.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Phytomedicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1